Brief: U.S. FDA Grants Icecure Medical's Appeal

Icecure Medical

30/01/2024 13:15

Jan 30 (Reuters) - Icecure Medical Ltd  ICCM.O :
    * U.S. FDA GRANTS ICECURE MEDICAL'S APPEAL: REOPENS DE NOVO
CLASSIFICATION REQUEST FOR MARKETING AUTHORIZATION OF PROSENSE®
FOR EARLY-STAGE BREAST CANCER
    * ICECURE MEDICAL LTD -ICECURE TO SUBMIT FULL 5-YEAR DATASET
FROM
ENTIRE ICE3 STUDY POPULATION TO FDA THIS SPRING
    * ICECURE MEDICAL LTD -FINAL ICE3 STUDY PATIENT IS EXPECTED
TO
COMPLETE HER 5-YEAR FOLLOW UP EXAMINATION BY END OF FEBRUARY
2024

Source text for Eikon:  ID:nPn9lPpmga 
Further company coverage:  ICCM.O 

 ((Reuters.Briefs@thomsonreuters.com;))